Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant

NCT02988115 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

345

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Atherosclerotic Cardiovascular Disease
Statin Adverse Reaction

Interventions

DRUG: bempedoic acid
OTHER: placebo

Sponsor

Esperion Therapeutics, Inc.